EVALUATION OF HEALTHCARE COSTS OF ELDERLY NONVALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH APIXABAN VS. RIVAROXABAN AND DABIGATRANS. Deitelzweig,X. Luo,K. Gupta,J. Trocio,J. Mardekian, T. Curtice, M. Lingohr-Smith, B. L. Menges,J. LinVALUE IN HEALTH(2017)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要